OCT 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/194331

Contents of this Issue


Page 22 of 134

October 2013 CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. Bernard Becker, MD, dies at 93 INDICATIONS: The AcrySof® IQ posterior chamber intraocular lens is intended for the replacement of the human lens to achieve visual correction of aphakia in adult patients following cataract surgery. This lens is intended for placement in the capsular bag. WARNING/PRECAUTION: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/beneft ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions. ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. Bernard Becker, MD B ernard Becker, MD, former head of the Department of Ophthalmology and professor emeritus of ophthalmology and visual sciences at Washington University School of Medicine in St. Louis, passed away at his home at the age of 93 on Aug. 28, after a long battle with lung cancer. He was well known for his work in glaucoma. Dr. Becker was born in New York City in 1920. He attended Princeton University and Harvard Medical School and then went on to complete his ophthalmic training as a fellow and resident at the Wilmer Eye Institute at Johns Hopkins. He began at Washington University in St. Louis in 1953, where he served as the Department of Ophthalmology chair from 1953 until 1988. Dr. Becker is known for his research and expertise in glaucoma and later co-authored the textbook Diagnosis and Therapy of the Glaucomas. He hoped to find a cure for the disease and discovered one of the first treatments for glaucoma. ÒHe had a remarkable knowledge of medicine and ophthalmology and an incredibly creative mind,Ó said Michael Kass, MD, professor and chairman of ophthalmology and visual sciences at Washington University School of Medicine in St. Louis. ÒHe was always looking for the things that would make us understand the fundamental defects and then unlock the secrets of diseases so that we could treat them better.Ó Dr. Becker played a key role in establishing the Association for Research in Vision and Ophthalmology (ARVO) and the National Eye Institute (NEI). He served as the president of ARVO in 1966, was the first editor-in-chief of Investigative Ophthalmology, served as a director of the American Board of Ophthalmology from 1967 to 1974, and was a founding member of the Association of University Professors of Ophthalmology (AUPO). He received numerous awards, including the Proctor Medal, the Friedenwald Award, the Mildred Weisenfeld Award, the American Academy of OphthalmologyÕs Laureate Recognition Award, and the Helen Keller Prize. Over his career, Dr. Becker authored and co-authored hundreds of publications on numerous topics. There are two professorships named after Dr. Becker at Washington University, and the university renamed its medical library in honor of him in 1995. ÒDr. Becker was one of the most prominent personalities of 20th century ophthalmology,Ó said Stephen Obstbaum, MD, professor of ophthalmology, Hofstra North Shore-LIJ School of Medicine, Hempstead, N.Y., and former glaucoma fellow of Dr. Becker at Washington University in St. Louis. ÒHe was an exceedingly bright, insightful individual, whose teachings served as a foundation of a reasoned approach to the management and treatment of glaucoma based on well-conceived experimental studies. ÒThe prominent role that many of the residents, fellows, and faculty he nurtured and trained have assumed in contemporary ophthalmology is also a testament to the importance of his role as a teacher, researcher, and clinician,Ó Dr. Obstbaum said. EW New Orleans fun facts Travel + Leisure Magazine ranked New Orleans as one of the top 10 cities in the United States and Canada in 2010. Most New Orleans street names are French and Spanish. The architecture is uniquely Creole. © 2013 Novartis 2/13 NIQ13007JAD

Articles in this issue

Archives of this issue

view archives of Eyeworld - OCT 2013